0
Skip to Content
Biologic Eye Drops
Home
FAQ
FAQ
Report problems to the FDA
Report deceptive advertising
Watch & Learn
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
History
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Biologic Eye Drops
Home
FAQ
FAQ
Report problems to the FDA
Report deceptive advertising
Watch & Learn
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
History
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Home
Folder: FAQ
Back
FAQ
Report problems to the FDA
Report deceptive advertising
Folder: Watch & Learn
Back
Browse All
A Patient's Story
DrB's Educational Presentations
Non-Preserved Eye Drop Safety
Regener-Eyes
StimulEyes
Sludge ™
The Placebo Effect
FDA Compliance
On Label, Off Label or No Label?
Placentas from Strangers
Folder: History
Back
DEF Open Letter to Key Opinion Leaders (Nov 7, 2024)
FDA Warning Letter to Regenerative Processing Plant (Aug 16, 2024)
FDA Warning Letter to Neobiosis (June 5, 2024)
FDA Inspection Form 483 - RPP Tampa (June 23, 2023)
FDA Inspection Form 483 - RPP Palm Harbor (June 30, 2023)
DEF Open Letter to the FDA (May 12, 2023)
DEF Open Letter to the Eye Care Press (May 5, 2023)
DEF Open Letter to ABB Optical and Dry Eye Rescue (May 1, 2023)
FDA Public Safety Notification on Amniotic Fluid Eyedrops (Apr 10, 2023)
DEF Open Letter re StimulEyes (Mar 9, 2023)
DEF Open Letter to Regener-Eyes (Mar 5, 2023)
FDA Untitled Letter re StimulEyes (Nov 17, 2022)
FDA Untitled Letter to Regener-Eyes (Oct 5, 2022)
DEF Open Letter to Regener-Eyes (Sep 29, 2022)
DEF Regulatory Compliance Summary Information (June 8, 2022)
DEF Open letter for Eye Care Professionals (May 16, 2022)
Featured
Diagnosing ScamPharma ® Part 6B: Smoke & Mirrors Redux
Aug 2, 2024
Diagnosing ScamPharma ® Part 6B: Smoke & Mirrors Redux
Aug 2, 2024

How to make sense of multiple Regener-Eyes facility inspections? The Regener-Eyes (Palm Harbor) manufacturing facility inspection was an "epic fail" but they've been quick to share that their Tampa storage facility was found to be compliant.

Aug 2, 2024
Diagnosing ScamPharma ® Part 6A: Dr. Social-Eyes Will See You Now
Aug 2, 2024
Diagnosing ScamPharma ® Part 6A: Dr. Social-Eyes Will See You Now
Aug 2, 2024

What's so unique about Regener-Eyes' ingredients if they've told the FDA the drops contain only salt, water and glycerin? How come eye doctors keep marketing these products?

Aug 2, 2024
Diagnosing ScamPharma ® Part 5B: “Regener-Eyes is in compliance with Federal laws” - You Missed One
Jun 6, 2023
Diagnosing ScamPharma ® Part 5B: “Regener-Eyes is in compliance with Federal laws” - You Missed One
Jun 6, 2023
Jun 6, 2023
Diagnosing ScamPharma ® Part 5A: The New White Paper Biopsy
May 4, 2023
Diagnosing ScamPharma ® Part 5A: The New White Paper Biopsy
May 4, 2023
May 4, 2023
Diagnosing Scam Pharma, Part 4B - Rebecca & Aidan go to Vision Expo West
Sep 19, 2022
Diagnosing Scam Pharma, Part 4B - Rebecca & Aidan go to Vision Expo West
Sep 19, 2022
Sep 19, 2022
Diagnosing Scam Pharma, Part 4A - Playing Whac-A-Mole with Regener-Eyes LLC
Sep 18, 2022
Diagnosing Scam Pharma, Part 4A - Playing Whac-A-Mole with Regener-Eyes LLC
Sep 18, 2022

Staying one step ahead of the feds. Bye-bye, “biologic”! Look, an indication! New OTC DailyMed listings. Are they lying to patients? Are they lying to the FDA? Oh, and where exactly does glycerin come from? No mole holes left.

Sep 18, 2022
Diagnosing Scam Pharma, Part 3 - It Has a Mermaid on It - It Must Be Okay!
Aug 23, 2022
Diagnosing Scam Pharma, Part 3 - It Has a Mermaid on It - It Must Be Okay!
Aug 23, 2022

DrB talks about Regener-Eyes past history (predecessor products) and the recent changes to their website. Gosh, it's nice to be noticed!

Aug 23, 2022
Diagnosing Scam Pharma, Part 2 - The Astonishing New Regener-Eyes Advertisement
Jul 14, 2022
Diagnosing Scam Pharma, Part 2 - The Astonishing New Regener-Eyes Advertisement
Jul 14, 2022
Jul 14, 2022
Diagnosing Scam Pharma, Part 1 - The Facebook Photos Biopsy
Jun 27, 2022
Diagnosing Scam Pharma, Part 1 - The Facebook Photos Biopsy
Jun 27, 2022

The Facebook Photos Biopsy. Seven telltale ad features.

Jun 27, 2022

About

Contact

Join Dry Eye Foundation mailing list(s)

Copyright © 2025. All rights reserved.